sotalol has been researched along with Graft-Versus-Host Disease in 1 studies
Sotalol: An adrenergic beta-antagonist that is used in the treatment of life-threatening arrhythmias.
sotalol : A sulfonamide that is N-phenylmethanesulfonamide in which the phenyl group is substituted at position 4 by a 1-hydroxy-2-(isopropylamino)ethyl group. It has both beta-adrenoreceptor blocking (Vaughan Williams Class II) and cardiac action potential duration prolongation (Vaughan Williams Class III) antiarrhythmic properties. It is used (usually as the hydrochloride salt) for the management of ventricular and supraventricular arrhythmias.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pasierb, MM | 1 |
| Seslar, SP | 1 |
1 other study available for sotalol and Graft-Versus-Host Disease
| Article | Year |
|---|---|
Intravenous sotalol use in a complex critically ill child: balancing the systems in choosing antiarrhythmic medication.
Topics: Administration, Intravenous; Adolescent; Anti-Arrhythmia Agents; Bone Marrow Transplantation; Echoca | 2017 |